Literature DB >> 18348259

Unique disease heritage of the Dutch-German Mennonite population.

Noelle C Orton1, A Micheil Innes, Albert E Chudley, N Torben Bech-Hansen.   

Abstract

The Dutch-German Mennonites are a religious isolate with foundational roots in the 16th century. A tradition of endogamy, large families, detailed genealogical records, and a unique disease history all contribute to making this a valuable population for genetic studies. Such studies in the Dutch-German Mennonite population have already contributed to the identification of the causative genes in several conditions such as the incomplete form of X-linked congenital stationary night blindness (CSNB2; previously iCSNB) and hypophosphatasia (HOPS), as well as the discovery of founder mutations within established disease genes (MYBPC1, CYP17alpha). The Dutch-German Mennonite population provides a strong resource for gene discovery and could lead to the identification of additional disease genes with relevance to the general population. In addition, further research developments should enhance delivery of clinical genetic services to this unique community. In the current review we discuss 31 genetic conditions, including 17 with identified gene mutations, within the Dutch-German Mennonite population. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18348259     DOI: 10.1002/ajmg.a.32061

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Amish, mennonite, and hutterite genetic disorder database.

Authors:  Michael Payne; C Anthony Rupar; Geoffrey M Siu; Victoria Mok Siu
Journal:  Paediatr Child Health       Date:  2011-03       Impact factor: 2.253

2.  Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging.

Authors:  Ida Surakka; Kati Kristiansson; Verneri Anttila; Michael Inouye; Chris Barnes; Loukas Moutsianas; Veikko Salomaa; Mark Daly; Aarno Palotie; Leena Peltonen; Samuli Ripatti
Journal:  Genome Res       Date:  2010-09-01       Impact factor: 9.043

3.  Of founder populations, long QT syndrome, and destiny.

Authors:  Paul A Brink; Peter J Schwartz
Journal:  Heart Rhythm       Date:  2009-09-03       Impact factor: 6.343

4.  Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites.

Authors:  Rachel Saunders-Pullman; Tania Fuchs; Marta San Luciano; Deborah Raymond; Alison Brashear; Robert Ortega; Andres Deik; Laurie J Ozelius; Susan B Bressman
Journal:  Mov Disord       Date:  2014-02-05       Impact factor: 10.338

5.  Geographical variation and factors associated with colorectal cancer mortality in a universal health care system.

Authors:  Mahmoud Torabi; Christopher Green; Zoann Nugent; Salaheddin Mahmud; Alain Demers; Jane Griffith; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

6.  A shared founder mutation underlies restrictive dermopathy in Old Colony (Dutch-German) Mennonite and Hutterite patients in North America.

Authors:  Catrina Loucks; Jillian S Parboosingh; Jessica X Chong; Carole Ober; Victoria M Siu; Robert A Hegele; C Anthony Rupar; D Ross McLeod; Alfredo Pinto; Albert E Chudley; A Micheil Innes
Journal:  Am J Med Genet A       Date:  2012-04-11       Impact factor: 2.802

Review 7.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

Review 8.  Alkaline Phosphatase Replacement Therapy.

Authors:  Maria Luisa Bianchi; Silvia Vai
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation.

Authors:  Etienne Mornet; Agnès Taillandier; Christelle Domingues; Annika Dufour; Emmanuelle Benaloun; Nicole Lavaud; Fabienne Wallon; Nathalie Rousseau; Carole Charle; Mihelaiti Guberto; Christine Muti; Brigitte Simon-Bouy
Journal:  Eur J Hum Genet       Date:  2020-09-24       Impact factor: 4.246

10.  A Dutch Fanconi Anemia FANCC Founder Mutation in Canadian Manitoba Mennonites.

Authors:  Yne de Vries; Nikki Lwiwski; Marieke Levitus; Bertus Kuyt; Sara J Israels; Fré Arwert; Michel Zwaan; Cheryl R Greenberg; Blanche P Alter; Hans Joenje; Hanne Meijers-Heijboer
Journal:  Anemia       Date:  2012-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.